SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-06-000776
Filing Date
2006-08-08
Accepted
2006-08-08 12:53:07
Documents
9
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a22629e10vq.htm 10-Q 274829
2 EXHIBIT 10.25 a22629exv10w25.htm EX-10.25 58388
3 EXHIBIT 10.26 a22629exv10w26.htm EX-10.26 39201
4 EXHIBIT 10.27 a22629exv10w27.htm EX-10.27 72105
5 EXHIBIT 10.28 a22629exv10w28.htm EX-10.28 44461
6 EXHIBIT 31.1 a22629exv31w1.htm EX-31.1 8381
7 EXHIBIT 31.2 a22629exv31w2.htm EX-31.2 8376
8 EXHIBIT 32.1 a22629exv32w1.htm EX-32.1 3238
9 EXHIBIT 32.2 a22629exv32w2.htm EX-32.2 3261
  Complete submission text file 0000936392-06-000776.txt   513682
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 061012072
SIC: 2836 Biological Products, (No Diagnostic Substances)